Havrix 1440iu One Dose Adult
KSh 2,944.00
Havrix 1440 IU is an inactivated hepatitis A vaccine meant for active immunization against hepatitis A virus (HAV) infection in adults. The vaccine provides long-term protection against hepatitis A, a viral infection that primarily affects the liver. It is available as a single-dose pre-filled syringe for convenient administration.Active Ingredient: Hepatitis A virus (inactivated) – 1440 ELISA Units per 1 mL.
Vaccine
Suggested Use
Havrix 1440 IU is indicated for:
- Prevention of hepatitis A: Especially in individuals traveling to endemic areas, healthcare workers, and those at occupational risk.
- Post-exposure prophylaxis: In certain cases, when administered within two weeks of exposure.
- Immunization in high-risk groups: Including those with chronic liver disease or close contact with an infected individual.
Dosage and Administration:
- Standard Dose: A single 1ml dose of Havrix 1440 IU administered intramuscularly (preferably in the deltoid region).
- Booster Dose: A second dose is recommended 6–12 months after the first dose to ensure long-term immunity.
- Special Considerations: For immunocompromised individuals or those with liver disease, consult a healthcare provider for tailored recommendations.
Warning
- Hypersensitivity: Do not administer to individuals with a known allergy to any component of the vaccine.
- Illness: Defer vaccination in individuals with acute febrile illness.
- Immune Deficiency: Reduced immune response may occur in immunocompromised individuals.
- Pregnancy and Lactation: Use only if clearly needed, as safety during pregnancy and breastfeeding has not been established.
- Syncope (fainting): May occur after or during injection; monitor patients for at least 15 minutes post-vaccination.
- Storage: Keep refrigerated at 2 °C–8 °C (do not freeze). Protect from light.
Side Effects:
Common adverse effects may include:
- Pain, redness, or swelling at the injection site
- Headache
- Fatigue
- Mild fever
- Nausea or loss of appetite
Seek immediate medical attention if severe allergic reactions, such as difficulty breathing or swelling of the face and throat, occur.
Note: Always consult a healthcare professional for further guidance tailored to your medical history and vaccination needs.